51
|
Varga A, Bakacs M, Zentai A, Nagy B, Nagy-Lőrincz Z, Erdei G, Illés É, Varga-Nagy V, Sarkadi Nagy E, Cserháti Z, Kaposvári C. Assessment of the public catering act in primary schools in Hungary. Eur J Public Health 2018. [DOI: 10.1093/eurpub/cky212.681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
52
|
Vuagnat P, Baldini C, Verlingue L, Martin Romano P, Varga A, Hollebecque A, Postel-Vinay S, Gazzah A, Bahleda R, Marabelle A, Ribrag V, Champiat S, Michot JM, Soria JC, Massard C. Molecular alterations and matched treatment in older patients: Results from the MOSCATO 01 trial. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy303.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
53
|
Bernard-Tessier A, Baldini C, Castanon Alvarez E, Ammari S, Martin Romano P, Champiat S, Hollebecque A, Postel-Vinay S, Varga A, Bahleda R, Gazzah A, Michot JM, Ribrag V, Armand JP, Marabelle A, Soria JC, Massard C. Patterns of progression to immune checkpoint targeted monoclonal antibodies in phase I trials. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy288.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
54
|
Baldini C, Martin-Romano P, Voisin AL, Danlos F, Champiat S, Laghouati S, Kfouri M, Vincent H, Nagera C, Postel-Vinay S, Varga A, Ribrag V, Besse B, Hollebecque A, Lambotte O, Michot JM, Soria JC, Massard C, Marabelle A. Incidence of immune related adverse events in patients 70 years old treated with anti-PD-(L)1 therapy. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy288.079] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
55
|
Houessinon A, Verlingue L, Hollebecque A, Even C, Lacroix L, Postel-Vinay S, Varga A, El Dakdouki Y, Balheda R, Michot JM, Gazzah A, Marabelle A, Michiels S, Rouleau E, Breuskin I, de Baere T, Angevin E, Scoazec JY, Soria JC, Massard C. Molecular screening in advanced cancer patients with head and neck cancers: A retrospective analysis of the MOSCATO-01 trial. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy287.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
56
|
Abdelshafy M, El Dakdouki Y, Verlingue L, Hollebecque A, Lacroix L, Postel-Vinay S, Varga A, Balheda R, Michot JM, Marabelle A, Rouleau E, Solary E, de Baere T, Angevin E, Ribrag V, Michiels S, André F, Scoazec JY, Soria JC, Massard C. Precision medicine for patients with rare cancers: An effective strategy within the prospective MOSCATO trial. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy303.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
57
|
Vozy A, Simonaggio A, Auclin E, Mezquita L, Baldini C, Martin-Romano P, Pistilli B, Gazzah A, Bahleda R, Ribrag V, Postel-Vinay S, Champiat S, Soria JC, André F, Massard C, Besse B, Delaloge S, Varga A. Applicability of the lung immune prognostic index (LIPI) to metastatic triple negative breast cancer (mTNBC) patients treated with immune checkpoint targeted monoclonal antibodies (ICT mAbs). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy272.286] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
58
|
Alsina M, Varga A, Amatu A, Schellens J, Witteveen P, Boni V, Moreno V, Bol K, Lourbakos A, Magin Ferrer M, Wasserman E. Phase I/II study of single agent MCLA-128, a full length IgG1 bispecific antibody targeting the HER3 pathway: Overall safety at the recommended phase II dose (R2PD) and preliminary activity in HER2+ metastatic gastric/gastroesophageal junction cancer (GC/GEJ). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy282.048] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
59
|
Nagy AI, Turani M, Apor A, Kolossvary M, Szilveszter B, Milanovich D, Panajotu A, Bartykowszki A, Varga A, Suhai F, Karady J, Jermendy A, Orosz P, Maurovich-Horvat P, Merkely B. P3421Improved cognitive performance following transcatheter aortic valve implantation despite the presence of lacunar cerebral lesions - a RETORIC sub-study. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
60
|
Zagatina A, Scali MC, Ciampi Q, Cortigiani L, Merlo PM, Djordjevic-Dikic A, Borguezan Daros C, Varga A, Wierzbowska-Drabik K, Kasprzak JD, Boshchenko A, Dekleva M, Simova I, Carpeggiani C, Picano E. P5626The functional meaning of the “Wet Lung” with B-line increase during stress echocardiography. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p5626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
61
|
Kam K, Pettibone W, Varga A. 0093 Dynamics Of Cortical Sleep Spindles And Slow Waves Following Motor Learning In Mice. Sleep 2018. [DOI: 10.1093/sleep/zsy061.092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
62
|
BUBU OM, Umasabor-Bubu OQ, Sharma RA, Mukhtar F, Smith AH, Mbah A, Borenstein A, Mortimer J, Seixas A, Jean-Louis G, Kip K, Morgan D, Varga A, Osorio R. 1007 Obstructive Sleep Apnea (OSA) Is Associated with Longitudinal Increases in Brain Florbetapir PET Imaging, CSF TAU, PTAU, And Decrease in CSF AB42 burden, In Elderly Cognitive Normal (NL) And Mild Cognitive Impairment (MCI) Individuals. Sleep 2018. [DOI: 10.1093/sleep/zsy061.1006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
63
|
Polyak A, Farkas A, Morvay N, Agoston G, Varga A, Lepran I, Baczko I, Varro A, Farkas AS. P475Investigation of cardiac morphological and electrophysiological changes of dogs after long time intensive exercise. Cardiovasc Res 2018. [DOI: 10.1093/cvr/cvy060.333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
64
|
Janovák L, Dernovics Á, Mérai L, Deák Á, Sebők D, Csapó E, Varga A, Dékány I, Janáky C. Microstructuration of poly(3-hexylthiophene) leads to bifunctional superhydrophobic and photoreactive surfaces. Chem Commun (Camb) 2018; 54:650-653. [DOI: 10.1039/c7cc07671a] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Schematic representation and a preparation route for the poly(3-hexylthiophene) conducting polymer film having both superhydrophobic and visible-light active photocatalytic properties.
Collapse
|
65
|
Hong D, Varga A, Parikh A, Shapiro G, Reyderman L, Ren M, Dayal S, Binder T, Ooi C, Ataman Ö, Marabelle A. Phase 1 study of E7046, a PGE2 receptor EP-4 inhibitor that targets immunosuppressive myeloid cells in the tumor microenvironment (TME). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx712.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
66
|
Reglodi D, Cseh S, Somoskoi B, Fulop BD, Szentleleky E, Szegeczki V, Kovacs A, Varga A, Kiss P, Hashimoto H, Tamas A, Bardosi A, Manavalan S, Bako E, Zakany R, Juhasz T. Disturbed spermatogenic signaling in pituitary adenylate cyclase activating polypeptide-deficient mice. Reproduction 2017; 155:129-139. [PMID: 29101268 DOI: 10.1530/rep-17-0470] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2017] [Revised: 10/18/2017] [Accepted: 11/03/2017] [Indexed: 12/20/2022]
Abstract
PACAP is a neuropeptide with diverse functions in various organs, including reproductive system. It is present in the testis in high concentrations, and in addition to the stage-specific expression within the seminiferous tubules, PACAP affects spermatogenesis and the functions of Leydig and Sertoli cells. Mice lacking endogenous PACAP show reduced fertility, but the possibility of abnormalities in spermatogenic signaling has not yet been investigated. Therefore, we performed a detailed morphological analysis of spermatozoa, sperm motility and investigated signaling pathways that play a role during spermatogenesis in knockout mice. No significant alterations were found in testicular morphology or motility of sperm in homozygous and heterozygous PACAP-deficient mice in spite of the moderately increased number of severely damaged sperms. However, we found robust changes in mRNA and/or protein expression of several factors that play an important role in spermatogenesis. Protein kinase A expression was markedly reduced, while downstream phospho-ERK and p38 were elevated in knockout animals. Expression of major transcription factors, such as Sox9 and phospho-Sox9, was decreased, while that of Sox10, as a redundant factor, was increased in PACAP-deficient mice. The reduced phospho-Sox9 expression was partly due to increased expression and activity of phosphatase PP2A in knockout mice. Targets of Sox transcription factors, such as collagen type IV, were reduced in knockout mice. In summary, our results show that lack of PACAP leads to disturbed signaling in spermatogenesis, which could be a factor responsible for reduced fertility in PACAP knockout mice, and further support the role of PACAP in reproduction.
Collapse
|
67
|
Gauci ML, Lanoy E, Champiat S, Michot JM, Varga A, Bahleda R, Angevin E, Gazzah A, Verlingue L, Bigot F, Aspeslagh S, Castanon E, Baldini C, Postel-Vinay S, Massard C, Hollebecque A, Soria JC, Marabelle A. Long term survival in patients responding to an Anti-PD-1/PD-L1 therapy and disease outcome upon treatment discontinuation. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx376.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
68
|
Herin H, Castanon E, Dyevre V, Aspeslagh S, Marabelle A, Postel-Vinay S, Varga A, Gazzah A, Ribrag V, Bahleda R, Michot JM, Mir O, Massard C, Hollebecque A, Soria JC, Baldini C. Immunotherapy phase I trials in patients over 70 years with advanced solid tumours: The Gustave Roussy experience. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx376.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
69
|
Hong D, Varga A, Parikh A, Shapiro G, Reyderman L, Ren M, Dayal S, Binder T, Ooi C, Ataman O, Marabelle A. Phase 1 Study of E7046, a PGE2 Receptor EP-4 inhibitor that targets immunosuppressive myeloid cells in the tumor microenvironment. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx367.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
70
|
Agoston G, Besenyi Z, Hemelein R, Palinkas A, Kovacs L, Pavics L, Varga A. P2424Detection of myocardial involvement in patients with systemic sclerosis by cardiac 18F-FDG PET/CT and speckle tracking echocardiography. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p2424] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
71
|
Ciampi Q, Paterni M, Borguezan Daros C, Simova I, Luis De Castro E Silva Pretto J, Scali M, Djorkievic-Dikic A, Kasprzak J, Zagatina A, Varga A, Amor M, Galderisi M, Citro R, Colonna P, Picano E. P562Upstream quality control of regional wall motion analysis in Stress Echo 2020. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx501.p562] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
72
|
Palinkas A, Katona A, Varga A, Ungi I, Kakonyi K, Sepp R, Thury A, Palinkas E, Kallai A, Nyuzo B, Csaszar I. P5247Effect of chronic total occlusion of right coronary artery on the flow velocity profile of left anterior descending coronary artery. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p5247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
73
|
Palinkas A, Nagy V, Varga A, Csaszar I, Kallai A, Palinkas E, Forster T, Kakonyi K, Agoston G, Sepp R. P561Paradoxical hemodynamic response in patients hypertrophic cardiomyopathy evaluated by supine bicycle stress echocardiography. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx501.p561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
74
|
Massard C, Mateo J, Loriot Y, Pezaro C, Albiges L, Mehra N, Varga A, Bianchini D, Ryan CJ, Petrylak DP, Attard G, Shen L, Fizazi K, de Bono J. Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone. Ann Oncol 2017; 28:90-95. [PMID: 28039155 PMCID: PMC5378222 DOI: 10.1093/annonc/mdw441] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
Background Abiraterone and cabazitaxel improve survival in patients with metastatic castration-resistant prostate cancer (mCRPC). We conducted an open-label phase I/II trial of cabazitaxel plus abiraterone to assess the antitumor activity and tolerability in patients with progressive mCRPC after docetaxel (phase I), and after docetaxel and abiraterone (phase II) (NCT01511536). Patients and methods The primary objectives were to determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLTs) of cabazitaxel plus abiraterone (phase I), and the prostate-specific antigen (PSA) response defined as a ≥ 50% decrease confirmed ≥3 weeks later with this combination (phase II). Results Ten patients were enrolled in the phase I component; nine were evaluable. No DLTs were identified. The MTD was established as the approved doses for both drugs (cabazitaxel 25 mg/m2 every 3 weeks and abiraterone 1000 mg once daily). Daily abiraterone treatment did not impact on cabazitaxel clearance. Twenty-seven patients received cabazitaxel plus abiraterone plus prednisone (5 mg twice daily) in phase II. The median number of cycles administered (cabazitaxel) was seven (range: 1-28). Grade 3-4 treatment-emergent adverse events included asthenia (in 5 patients; 14%), neutropenia (in 5 patients; 14%) and diarrhea (in 3 patients; 8%). Nine patients (24%) required dose reductions of cabazitaxel. Of 26 evaluable patients, 12 achieved a PSA response [46%; 95% confidence interval (CI): 26.6-66.6%]. Median PSA-progression-free survival was 6.9 months (95% CI: 4.1-10.3 months). Of 14 patients with measurable disease at baseline, 3 (21%) achieved a partial response per response evaluation criteria in solid tumors. Conclusions The combination of cabazitaxel and abiraterone has a manageable safety profile and shows antitumor activity in patients previously treated with docetaxel and abiraterone.
Collapse
|
75
|
Fürjes G, Lelesz B, Tóth GK, Arday A, Szilvássy Z, Varga A, Berényi E, Németh J. Comparative distribution of somatostatin and thrittene bioactive peptides in the central nervous system of rat measured by radioimmunoassay. J Radioanal Nucl Chem 2017. [DOI: 10.1007/s10967-016-5132-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|